Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to -$6.6 million.

  • Rallybio's Cash from Operations rose 5164.27% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.0 million, marking a year-over-year increase of 3146.77%. This contributed to the annual value of -$49.3 million for FY2024, which is 1822.45% up from last year.
  • According to the latest figures from Q3 2025, Rallybio's Cash from Operations is -$6.6 million, which was up 5164.27% from -$8.4 million recorded in Q2 2025.
  • In the past 5 years, Rallybio's Cash from Operations registered a high of -$6.6 million during Q3 2025, and its lowest value of -$18.8 million during Q1 2023.
  • For the 3-year period, Rallybio's Cash from Operations averaged around -$12.2 million, with its median value being -$11.6 million (2023).
  • In the last 5 years, Rallybio's Cash from Operations surged by 1531.13% in 2024 and then skyrocketed by 5164.27% in 2025.
  • Rallybio's Cash from Operations (Quarter) stood at -$11.6 million in 2023, then increased by 15.31% to -$9.9 million in 2024, then surged by 33.58% to -$6.6 million in 2025.
  • Its Cash from Operations stands at -$6.6 million for Q3 2025, versus -$8.4 million for Q2 2025 and -$10.2 million for Q1 2025.